10 April 2025 (Thursday) - Oncology Central Update

The nice people at Oncology Central sent their newsletter today. Much of it went over my head, but some might just have stuck

Newsletter 10 April 2025

Rapid approach developed for personalized pediatric cancer care   Researchers have developed a method for identifying personalized treatments for young cancer patients within an actionable timeframe.   READ MORE >>>

Could OTUD6B enable more targeted treatment options for TNBC?   READ MORE >>>

Pharma USA 2025: key takeaways and speaker highlights   READ MORE >>>

Do firefighters have an increased risk of glioma?   READ MORE >>>

JOURNAL ARTICLES

Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry READ THE ARTICLE >>>

Recent advances in immune checkpoint inhibitors for TNBC READ THE ARTICLE >>>

Enzalutamide in biochemically recurrent prostate cancer: key findings from the EMBARK study READ THE ARTICLE >>>

Discover more journal content

Topics: Cancer biology and pathology | Clinical trials | Drug approvals | Drug development | Diagnostics | Epidemiology | Genetics and genomics | Immuno- oncology | Industry and business | Patient perspective | Personalized medicine | Preclinical research and trials | Prevention and screening | Targeted therapies |